EGFR and metastatic colorectal cancer: The aim of the study was to investigate the efficacy of irinotecan-releasing beads in the treatment of metastatic colorectal cancer after prior cetuximab monotherapy in patients with metastatic colorectal cancer, as it has been suggested that the development of resistance to anti-EGFR antibodies may result in resistance to irinotecan.